Andrew J. Last Bio Rad Laboratories, Inc. (BIO) insider trading activity

Andrew J. Last is EVP, Chief Operating Officer of BIO-RAD LABORATORIES, INC.. Currently has a direct ownership of 7,559 shares of BIO, which is worth approximately $2.5 Million. The most recent transaction as insider was on Sep 06, 2024, when has been sold 3,000 shares (Bio-Rad A Common Stock) at a price of $329.94 per share, resulting in proceeds of $989,820. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.56K

0% 3M change

50.01% 12M change

Total Value Held $2.5 Million

Andrew J. Last Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 06 2024	SELL Open market or private sale	$989,820 $329.94 p/Share	3,000 Reduced 28.41%	7,559 Bio-Rad A Common Stock
Sep 06 2024	BUY Exercise of conversion of derivative security	$897,720 $299.24 p/Share	3,000 Added 22.13%	10,559 Bio-Rad A Common Stock
Sep 02 2024	SELL Payment of exercise price or tax liability	$154,492 $337.32 p/Share	458 Reduced 5.71%	7,559 Bio-Rad A Common Stock
Sep 02 2024	BUY Exercise of conversion of derivative security	-	903 Added 10.12%	8,017 Bio-Rad A Common Stock
Sep 01 2024	SELL Payment of exercise price or tax liability	$470,898 $337.32 p/Share	1,396 Reduced 16.4%	7,114 Bio-Rad A Common Stock
Sep 01 2024	BUY Exercise of conversion of derivative security	-	2,752 Added 27.01%	7,435 Bio-Rad A Common Stock
Apr 29 2024	SELL Payment of exercise price or tax liability	$98,928 $277.11 p/Share	357 Reduced 5.88%	5,719 Bio-Rad A Common Stock
Apr 29 2024	BUY Exercise of conversion of derivative security	-	1,000 Added 14.13%	6,076 Bio-Rad A Common Stock
Sep 02 2023	SELL Payment of exercise price or tax liability	$176,780 $394.6 p/Share	448 Reduced 8.16%	5,039 Bio-Rad A Common Stock
Sep 02 2023	BUY Exercise of conversion of derivative security	-	903 Added 14.13%	5,487 Bio-Rad A Common Stock
Sep 01 2023	SELL Payment of exercise price or tax liability	$279,771 $394.6 p/Share	709 Reduced 13.4%	4,584 Bio-Rad A Common Stock
Sep 01 2023	BUY Exercise of conversion of derivative security	-	1,500 Added 23.57%	4,863 Bio-Rad A Common Stock
Apr 29 2023	SELL Payment of exercise price or tax liability	$155,973 $450.79 p/Share	346 Reduced 8.41%	3,766 Bio-Rad A Common Stock
Apr 29 2023	BUY Exercise of conversion of derivative security	-	1,000 Added 19.56%	4,112 Bio-Rad A Common Stock
Sep 02 2022	SELL Payment of exercise price or tax liability	$214,287 $478.32 p/Share	448 Reduced 12.69%	3,083 Bio-Rad A Common Stock
Sep 02 2022	BUY Exercise of conversion of derivative security	-	902 Added 20.35%	3,531 Bio-Rad A Common Stock
Sep 01 2022	SELL Payment of exercise price or tax liability	$152,682 $486.25 p/Share	314 Reduced 10.67%	2,629 Bio-Rad A Common Stock
Sep 01 2022	BUY Exercise of conversion of derivative security	-	633 Added 17.7%	2,943 Bio-Rad A Common Stock
Apr 29 2022	SELL Payment of exercise price or tax liability	$241,180 $512.06 p/Share	471 Reduced 17.04%	2,293 Bio-Rad A Common Stock
Apr 29 2022	BUY Exercise of conversion of derivative security	-	1,000 Added 26.57%	2,764 Bio-Rad A Common Stock
Sep 02 2021	SELL Payment of exercise price or tax liability	$369,945 $825.77 p/Share	448 Reduced 20.52%	1,735 Bio-Rad A Common Stock
Sep 02 2021	BUY Exercise of conversion of derivative security	-	902 Added 29.24%	2,183 Bio-Rad A Common Stock
Sep 01 2021	SELL Open market or private sale	$1,626,340 $813.17 p/Share	2,000 Reduced 60.96%	1,281 Bio-Rad A Common Stock
Sep 01 2021	BUY Exercise of conversion of derivative security	$598,480 $299.24 p/Share	2,000 Added 37.87%	3,281 Bio-Rad A Common Stock
Apr 29 2021	SELL Payment of exercise price or tax liability	$298,580 $640.73 p/Share	466 Reduced 26.89%	1,267 Bio-Rad A Common Stock

Also insider at

OCX

Oncocyte Corp Healthcare

Director

AJL

Andrew J. Last

EVP, Chief Operating Officer

Irvine, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BIO shares.

Notify only if

Value

Insider Trading

Get notified when an Bio Rad Laboratories, Inc. insider buys or sells BIO shares.

Notify only if

Operation

Value

Type

News

Receive news related to BIO-RAD LABORATORIES, INC.

Track Activities on BIO

Account